A review of treatment of uterine leiomyosarcomas.

about

Oncogenic HrasG12V expression plus knockdown of Cdkn2a using ecotropic lentiviral vectors induces high-grade endometrial stromal sarcoma.

P2860

Q41923500-476AE482-800D-4432-9584-7228B5950A34

P2860

A review of treatment of uterine leiomyosarcomas.

Item

http://www.wikidata.org/entity/Q38153648

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

A review of treatment of uterine leiomyosarcomas.

@en

type

Item

label

A review of treatment of uterine leiomyosarcomas.

@en

prefLabel

A review of treatment of uterine leiomyosarcomas.

@en

P1476

A review of treatment of uterine leiomyosarcomas.

@en

P2093

Nicholas Reed

http://www.w3.org/2001/XMLSchema#string

P2860

Phase II trial of topotecan in patients with advanced, persistent, or recurrent uterine leiomyosarcomas: a Gynecologic Oncology Group Study.

Systemic therapy for advanced uterine sarcoma: a systematic review of the literature.

Phase II trial of paclitaxel in leiomyosarcoma of the uterus: a gynecologic oncology group study.

Phase II study of mitomycin, doxorubicin, and cisplatin in the treatment of advanced uterine leiomyosarcoma: a Gynecologic Oncology Group study.

Gemcitabine and docetaxel in patients with unresectable leiomyosarcoma: results of a phase II trial.

Evaluation of paclitaxel in previously treated leiomyosarcoma of the uterus: a gynecologic oncology group study.

Phase II trial of ifosfamide and mesna in leiomyosarcoma of the uterus: a Gynecologic Oncology Group study.

Fixed-dose rate gemcitabine plus docetaxel as first-line therapy for metastatic uterine leiomyosarcoma: a Gynecologic Oncology Group phase II trial.

A phase II evaluation of trabectedin in the treatment of advanced, persistent, or recurrent uterine leiomyosarcoma: a gynecologic oncology group study.

Phase II trial of ifosfamide and mesna in mixed mesodermal tumors of the uterus (a Gynecologic Oncology Group study).

P2888

s11912-013-0350-4

P304

581-587

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11912-013-0350-4

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2013-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1015795394

http://www.w3.org/2001/XMLSchema#string

P698

24136566

http://www.w3.org/2001/XMLSchema#string

A review of treatment of uterine leiomyosarcomas.

about

P2860

P2860

A review of treatment of uterine leiomyosarcomas.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P6179

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P6179

P698